Učitavanje...
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report
INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...
Spremljeno u:
| Izdano u: | J Med Case Rep |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/ https://ncbi.nlm.nih.gov/pubmed/25488584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|